These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 36549722)

  • 1. How soon should patients be eligible for differentiated service delivery models for antiretroviral treatment? Evidence from a retrospective cohort study in Zambia.
    Jamieson L; Rosen S; Phiri B; Grimsrud A; Mwansa M; Shakwelele H; Haimbe P; Mukumbwa-Mwenechanya M; Lumano-Mulenga P; Chiboma I; Nichols BE
    BMJ Open; 2022 Dec; 12(12):e064070. PubMed ID: 36549722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Attrition from HIV treatment after enrollment in a differentiated service delivery model: A cohort analysis of routine care in Zambia.
    Jo Y; Jamieson L; Phiri B; Grimsrud A; Mwansa M; Shakwelele H; Haimbe P; Mukumbwa-Mwenechanya M; Mulenga PL; Nichols BE; Rosen S
    PLoS One; 2023; 18(3):e0280748. PubMed ID: 36917568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV care retention in three multi-month ART dispensing: a retrospective cohort study in Mozambique.
    Saura-Lázaro A; Augusto O; Fernández-Luis S; López-Varela E; Fuente-Soro L; Bila D; Tovela M; Macuacua N; Vaz P; Couto A; Bruno C; Naniche D
    AIDS; 2024 Jul; 38(9):1402-1411. PubMed ID: 38652496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Longitudinal engagement trajectories and risk of death among new ART starters in Zambia: A group-based multi-trajectory analysis.
    Mody A; Eshun-Wilson I; Sikombe K; Schwartz SR; Beres LK; Simbeza S; Mukamba N; Somwe P; Bolton-Moore C; Padian N; Holmes CB; Sikazwe I; Geng EH
    PLoS Med; 2019 Oct; 16(10):e1002959. PubMed ID: 31661487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Community-based delivery of HIV treatment in Zambia: costs and outcomes.
    Nichols BE; Cele R; Jamieson L; Long LC; Siwale Z; Banda P; Moyo C; Rosen S
    AIDS; 2021 Feb; 35(2):299-306. PubMed ID: 33170578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estimating the real-world effects of expanding antiretroviral treatment eligibility: Evidence from a regression discontinuity analysis in Zambia.
    Mody A; Sikazwe I; Czaicki NL; Wa Mwanza M; Savory T; Sikombe K; Beres LK; Somwe P; Roy M; Pry JM; Padian N; Bolton-Moore C; Holmes CB; Geng EH
    PLoS Med; 2018 Jun; 15(6):e1002574. PubMed ID: 29870531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preferences for services in a patient's first six months on antiretroviral therapy for HIV in South Africa and Zambia (PREFER): research protocol for a prospective observational cohort study.
    Maskew M; Ntjikelane V; Juntunen A; Scott N; Benade M; Sande L; Hasweeka P; Haimbe P; Lumano-Mulenga P; Shakewelele H; Mukumbwa-Mwenechanya M; Rosen S
    Gates Open Res; 2023; 7():119. PubMed ID: 38343769
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differentiated service delivery models among PLHIV in Akwa Ibom and Cross River States, Nigeria during the COVID-19 pandemic: descriptive analysis of programmatic data.
    Sanwo O; Persaud NE; Nwaokoro P; Idemudia A; Akpan U; Toyo O; Imohi P; Badru T; Obiora-Okafo C; Uzochukwu CE; Aliu O; Olatunbosun K; Pandey SR; Khamofu H; Chiegil R; James E; Iyortim I; Oqua D; Bateganya M
    J Int AIDS Soc; 2021 Oct; 24 Suppl 6(Suppl 6):e25820. PubMed ID: 34713591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Participation in adherence clubs and on-time drug pickup among HIV-infected adults in Zambia: A matched-pair cluster randomized trial.
    Roy M; Bolton-Moore C; Sikazwe I; Mukumbwa-Mwenechanya M; Efronson E; Mwamba C; Somwe P; Kalunkumya E; Lumpa M; Sharma A; Pry J; Mutale W; Ehrenkranz P; Glidden DV; Padian N; Topp S; Geng E; Holmes CB
    PLoS Med; 2020 Jul; 17(7):e1003116. PubMed ID: 32609756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in HIV treatment differentiated care uptake during the COVID-19 pandemic in Zambia: interrupted time series analysis.
    Jo Y; Rosen S; Sy KTL; Phiri B; Huber AN; Mwansa M; Shakwelele H; Haimbe P; Mwenechanya MM; Lumano-Mulenga P; Nichols BE
    J Int AIDS Soc; 2021 Oct; 24 Suppl 6(Suppl 6):e25808. PubMed ID: 34713620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Eligibility for differentiated models of HIV treatment service delivery: an estimate from Malawi and Zambia.
    Hoffman RM; Balakasi K; Bardon AR; Siwale Z; Hubbard J; Kakwesa G; Haambokoma M; Kalua T; Pisa P; Moyo C; Dovel K; Xulu T; Sanne I; Fox M; Rosen S
    AIDS; 2020 Mar; 34(3):475-479. PubMed ID: 31764076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Client and provider preferences for HIV care: Implications for implementing differentiated service delivery in Thailand.
    Lujintanon S; Amatavete S; Sungsing T; Seekaew P; Peelay J; Mingkwanrungruang P; Chinbunchorn T; Teeratakulpisarn S; Methajittiphan P; Leenasirima P; Norchaiwong A; Nilmanat A; Phanuphak P; Ramautarsing RA; Phanuphak N
    J Int AIDS Soc; 2021 Apr; 24(4):e25693. PubMed ID: 33792192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High rates of loss to follow-up during the first year of pre-antiretroviral therapy for HIV patients at sites providing pre-ART care in Nigeria, 2004-2012.
    Agolory SG; Auld AF; Odafe S; Shiraishi RW; Dokubo EK; Swaminathan M; Dalhatu I; Onotu D; Abiri O; Debem H; Bashorun A; Ellerbrock TV
    PLoS One; 2017; 12(9):e0183823. PubMed ID: 28863160
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of loss to follow-up among children on long-term antiretroviral therapy in Zambia (2003-2015).
    Mutanga JN; Mutembo S; Ezeamama AE; Song X; Fubisha RC; Mutesu-Kapembwa K; Sialondwe D; Simuchembu B; Chinyonga J; Thuma PE; Whalen CC
    BMC Public Health; 2019 Aug; 19(1):1120. PubMed ID: 31416432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differentiated service delivery for people using second-line antiretroviral therapy: clinical outcomes from a retrospective cohort study in KwaZulu-Natal, South Africa.
    Lewis L; Sookrajh Y; Gate K; Khubone T; Maraj M; Mkhize S; Hermans LE; Ngobese H; Garrett N; Dorward J
    J Int AIDS Soc; 2021 Oct; 24 Suppl 6(Suppl 6):e25802. PubMed ID: 34713545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss to follow-up before and after initiation of antiretroviral therapy in HIV facilities in Lilongwe, Malawi.
    Tweya H; Oboho IK; Gugsa ST; Phiri S; Rambiki E; Banda R; Mwafilaso J; Munthali C; Gupta S; Bateganya M; Maida A
    PLoS One; 2018; 13(1):e0188488. PubMed ID: 29373574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Satisfaction with service delivery among HIV treatment clients enrolled in differentiated and conventional models of care in South Africa: a baseline survey.
    Mokhele I; Huber A; Rosen S; Kaiser JL; Lekodeba N; Ntjikelane V; Hendrickson C; Scott N; Pascoe S
    J Int AIDS Soc; 2024 Mar; 27(3):e26233. PubMed ID: 38528370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mortality estimates by age and sex among persons living with HIV after ART initiation in Zambia using electronic medical records supplemented with tracing a sample of lost patients: A cohort study.
    Kerkhoff AD; Sikombe K; Eshun-Wilson I; Sikazwe I; Glidden DV; Pry JM; Somwe P; Beres LK; Simbeza S; Mwamba C; Bukankala C; Hantuba C; Moore CB; Holmes CB; Padian N; Geng EH
    PLoS Med; 2020 May; 17(5):e1003107. PubMed ID: 32401797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Community-based differentiated service delivery models incorporating multi-month dispensing of antiretroviral treatment for newly stable people living with HIV receiving single annual clinical visits: a pooled analysis of two cluster-randomized trials in southern Africa.
    Fatti G; Ngorima-Mabhena N; Tiam A; Tukei BB; Kasu T; Muzenda T; Maile K; Lombard C; Chasela C; Grimwood A
    J Int AIDS Soc; 2021 Oct; 24 Suppl 6(Suppl 6):e25819. PubMed ID: 34713614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Longitudinal Care Cascade Outcomes Among People Eligible for Antiretroviral Therapy Who Are Newly Linking to Care in Zambia: A Multistate Analysis.
    Mody A; Glidden DV; Eshun-Wilson I; Sikombe K; Simbeza S; Mukamba N; Somwe P; Beres LK; Pry J; Bolton-Moore C; Padian N; Holmes CB; Sikazwe I; Geng EH
    Clin Infect Dis; 2020 Dec; 71(10):e561-e570. PubMed ID: 32173743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.